Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty

Coronary Artery Disease

Volumn 23, Issue 4, 2012, Pages 265-270

  Aslanger, Emre ^a   Uslu, Bora ^a   Akdeniz, Cansu ^a   Polat, Nihat ^a   Cizgici, Yasar ^a   Oflaz, Huseyin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

contrast induced nephropathy; N acetylcysteine; primary angioplasty

Indexed keywords

ACETYLCYSTEINE; CREATININE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; PLACEBO;

ACUTE HEART INFARCTION; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FIRST PASS EFFECT; HEART EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACETYLCYSTEINE; AGED; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; IOXAGLIC ACID; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RENAL ARTERY; TREATMENT OUTCOME;

EID: 84860837636     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328351aacc     Document Type: Article

References (16)

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997; 103:368-375. (Pubitemid 27506242)
2. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105:2259-2264. (Pubitemid 34535335)
3. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous interventions. J Am Coll Cardiol 2002; 39:1113-1119. (Pubitemid 34267412)
4. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108:2769-2775. (Pubitemid 37498979)
5. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44:1780-1785. (Pubitemid 39424075)
6. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354:2773-2782. (Pubitemid 43974195)
7. Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado César LA, Seguro AC. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 2004; 19:1803-1807. (Pubitemid 38961391)
8. Lopez BL, Snyder JW, Birenbaum DS, Ma XI. N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery. Ann Emerg Med 1998; 32:405-410. (Pubitemid 28495767)
9. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Circulation 1995; 92:2855-2862.
10. Baker CSR, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 2003; 41:2114-2118. (Pubitemid 36724254)
11. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, et al. Acetylcysteine and contrast agent associated nephrotoxicity. J Am Coll Cardiol 2002; 40:298-303. (Pubitemid 34756291)
12. Mc Clennan BL, Stolberg HO. Intravascular contrast media. Ionic versus nonionic: current status. Radiol Clin N Am 1991; 29:437-454.
13. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TM, Bashore TM. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N EngI J Med 1989; 320:149-153. (Pubitemid 19033092)
14. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41:1274-1279.
15. Berwanger O. Acetylcysteine for the Prevention of Contrast-Induced Nephropathy (ACT) Trial. [Abstract] American Heart Association (AHA) Scientific Sessions 2010; 21843.
16. Szummer K, Lundman P, Jacobson SH, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T. Cockroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction (SWEDEHEART). Am Heart J 2010; 159:979-986.